Nautilus Biosciences a part of Croda International Plc.

Nautilus Biosciences Canada Inc. is a marine biotechnology company, founded in 2007 by Professor Russell Kerr and based at the University of Prince Edward Island. The company specializes in blue biotechnology, utilizing marine microbial biodiversity to discover novel actives and materials. As a wholly owned subsidiary of Croda International Plc, Nautilus operates as Croda's Centre of Innovation for Marine Biotechnology. The company maintains exclusive global access to a specialized Marine Microbial Library and employs advanced, automated high-throughput screening technologies to identify sustainable, natural functional ingredients derived from marine microorganisms.

This research capability is critical for Croda's efforts to expand its portfolio of sustainable, biotechnology-derived ingredients for personal, health, and crop care markets. By integrating Nautilus into the Croda Group, the company bridges the gap between fundamental academic research and commercial application, helping Croda transition from a manufacturer of specialty chemicals into an organization driven by sustainable, bio-based innovation. The partnership leverages years of collaborative research to bring unique, patented products to global customers, while simultaneously strengthening the bioscience research cluster in Atlantic Canada.